Pentwater Capital Management’s Surgery Partners SGRY Stock Holding History

Pentwater Capital Management’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$151M	Buy	12,655,000 +2,655,000	+27%	+$38.1M	0.78%	29
2025 Q4	$155M	Sell	10,000,000 -1,681,000	-14%	-$30.9M	0.81%	22
2025 Q3	$253M	Buy	11,681,000 +4,681,000	+67%	+$104M	1.41%	19
2025 Q2	$156M	Buy	7,000,000 +4,258,000	+155%	+$94.6M	1.01%	21
2025 Q1	$65.1M	Buy	2,742,000 +2,317,000	+545%	+$54.8M	0.55%	31
2024 Q4	$9M	Buy	+425,000	New	+$11.2M	0.1%	60

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

KSCM

King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Pentwater Capital Management's SGRY Position: Q1 2026 in Review

Pentwater Capital Management increased its Surgery Partners (SGRY) stake by 27% in Q1 2026, buying an estimated $38.1M and bringing the position to 12,655,000 shares worth $151M. The position accounts for 0.78% of the portfolio, ranked #29.

Pentwater Capital Management first reported a position in SGRY in Q4 2024 and has held it in 6 quarters since. The position peaked at $253M in Q3 2025. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

Pentwater Capital Management held 12,655,000 shares of Surgery Partners worth $151M as of Q1 2026.
Pentwater Capital Management bought 2,655,000 Surgery Partners shares in Q1 2026, an estimated $38.1M.
Surgery Partners made up 0.78% of Pentwater Capital Management's portfolio in Q1 2026, its #29 holding.
Pentwater Capital Management first reported a position in Surgery Partners in Q4 2024 and has held it in 6 quarters since.
Pentwater Capital Management's Surgery Partners position peaked at $253M in Q3 2025.
182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on Pentwater Capital Management's 13F filing for Q1 2026, filed 15 May 2026.